4//SEC Filing
Gabay Avraham 4
Accession 0001213900-21-007494
CIK 0001176309other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:29 PM ET
Size
5.5 KB
Accession
0001213900-21-007494
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-03+40,000→ 40,000 totalExercise: $10.40Exp: 2031-02-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The Stock Option will vest in 4 equal installments as follows: 10,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001777328
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:29 PM ET
- Size
- 5.5 KB